Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07273669

Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Salerno · Academic / Other
Sex
All
Age
60 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate whether LOLE.K, a new and specialized robotic bed, is effective in the rehabilitation of patients who have undergone surgery. The primary objectives of the trial are: * Efficacy of LOLE.K: Does the LOLE.K robotic bed improve early rehabilitation in patients who undergone cardiac surgery? * Impact on recovery: Does LOLE.K influence wound healing, muscle and neurological recovery, and psychological well-being? To address these questions, the researchers will compare the use of LOLE.K with standard physical therapy to determine whether the robotic bed results in better outcomes in post-operative rehabilitation.

Detailed description

The goal of this clinical trial is to learn whether LOLE.K, a new and specialized robotic bed, works for rehabilitation of patients following surgery. The main research questions are: 1. Is LOLE.K effictive in enhancing early rehabilitation among patients who have undergone cardiac surgery? 2. Does LOLE.K influence wound healing, muscular and neurological recovery, and psychological well-being? Researchers will compare LOLE.K bed to the usual therapy to see if LOLE.K woks better than standard post-operation rehabilitation. 1. Project Objectives Primary Objective: To assess the effectiveness of multirole robotic beds (LOLE.K) for early rehabilitation in cardiac surgery patients. 2. Target Population Patients: individuals aged 60-85 years undergoing aortic and mitral valve surgery. Study Sites: University of Salerno Hospital and IRCCS Ospedale Galeazzi-Sant'Ambrogio. 3. Experimental Design: * Control Group: Standard post-operative rehabilitation. * Experimental Group: Rehabilitation using LOLE.K robotic beds. 4. Key phases \- Pilot Phase (Months 1-6): Define dataset structure, initiate patient enrollement and refine the operational algorithm. \- Enrollment Phase (Months 6-12): Collect demographic, clinical, and physical health data from enrolled patients. \- Follow-Up \& Analysis Phase (Months 12-24): Perform in-depth statistical analysis and finalize outcome evalitaion. 5. Data Colection Data Types: Demographic, clinical, physical, echocardiographic, and wound-healing data. Devices: LOLE.K robotic beds and echography machines. 6. Outcomes \& Measurements * Primary Outocomes: Lenght of hospital stay, ICU requirements, and rehabilitation time. * Secondary: Lung function, mental health scores, wound-healing scores, quality of life and cardiac output improvements. Standardized protocols for sedation and analgesia management will be applied, including the Richmond Agitation-Sedation Scale (RASS) for sedation and the Behavioral Pain Scale (BPS) or Critical Pain Observation Tool (CPOT) for pain. Also, delirium will be assessed using the Confusion Assessment Method for ICU (CAM-ICU). These parametres are critical: if patients are overly sedated or inadequately anesthetized, the results on mobilization could be confounded by these factors. Assessment of delirium is important because early mobilization could also have beneficial effects on cognitive status. 7. Statistical Analysis Plan * Descriptive Statistics: To provide an overview of baseline data. * Regression Models: To analyze the impact of key variables on clinical outcomes. * Machine Learning Models: To evaluate treatment efficiency based on patient data. 8. Expected Outcomes The use of LOLE.K is expected to result in faster recovery times, reduced ICU stays, improved physical and mental health, and enhanced wound healing compared with standard post-operative rehabilitation.

Conditions

Interventions

TypeNameDescription
DEVICEuse of the robotic beduse of the robotic bed LOLE.K for the early rehabilitation

Timeline

Start date
2025-09-22
Primary completion
2026-05-01
Completion
2027-01-01
First posted
2025-12-09
Last updated
2025-12-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07273669. Inclusion in this directory is not an endorsement.